PENN Capital Management »

Genes shares owned by PENN Capital Management

Quarter-by-quarter ownership of Genes (GCO) shares owned by PENN Capital Management from 13F filings

Historical chart of PENN Capital Management investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by PENN Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by PENN Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $531k 16k 33.77

More positions owned by PENN Capital Management

Ouster Com New (OUST)
Acm Resh Com Cl A (ACMR)
Mirum Pharmaceuticals (MIRM)
Ligand Pharmaceuticals Com New (LGND)
Tg Therapeutics (TGTX)
Rxo Common Stock (RXO)
Legence Corp Cl A (LGN)
Seaworld Entertainment (PRKS)
Penn National Gaming (PENN)
Wolfspeed Common Stock (WOLF)
Compass Cl A (COMP)
Banc Of California (BANC)
Select Water Solutions Cl A Com (WTTR)
Agilysys (AGYS)
Constellium Se Cl A Shs (CSTM)

View all positions for PENN Capital Management

Top funds holding Genes

Pzena Investment Management
BlackRock
Dimensional Fund Advisors
Fund 1 Investments
Acadian Asset Management
Vanguard Capital Management
Citadel Advisors
Healthcare Of Ontario Pension Plan Trust Fund
Charles Schwab Investment Management
Sixth Street Partners Management Company
Jacobs Levy Equity Management
D. E. Shaw & Co
Geode Capital Management
Vanguard Portfolio Management
Kingdon Capital Management

View all funds holding Genes